<DOC>
	<DOCNO>NCT02357940</DOCNO>
	<brief_summary>The purpose 14-day , two phase clinical study test tolerance new over-the-counter moisturizing balm subject eczema .</brief_summary>
	<brief_title>Tolerance Evaluation Nighttime Moisturizing Balm Babies Adults With Eczema</brief_title>
	<detailed_description>At least 60 subject enrol ensure 40 ( 10 adult 30 baby ) complete subject . The tolerability formulation monitor small group ten adult subject mild moderate eczema prior test baby . In Group A , adult ask give informed consent evaluation inclusion/exclusion criterion perform site . After screen , subject ask use skin treatment next clinic visit . Subjects use investigational product indicate least twice per day face - cheek , arm , leg torso 14 day . For adults baby , baseline measurement collect 5-10 minute first application , Day 1 , Day 7 Day 14 visit . Babies 6 36 month age mild moderate eczema , meet eligibility criterion , follow similar testing direction Group B study .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>1 . Male female race ethnicity , 6 month 36 month age and/or 18 year . 2 . Adult subject Male nonpregnant , nonlactating female agree contraceptive requirement ( include female partner use highly effective form birth control 3 month . 3 . Diagnosed Eczema . 4 . Willing stop use non assign moisturizers and/or cream entire duration study . 5 . Willing introduce new fragrance ( e.g . cleanser , lotion , perfume , etc . ) , household environment ( e.g . room freshener , cleanse agent , laundry detergent , etc . ) duration study . 6 . Willing avoid excessive ( 30 minute ) sun exposure without use regular brand sunscreen protective clothing . 7 . Willing enter/use hot tub whirlpool bath duration study . 8 . Willing avoid beach course study , willing document activity swim pool daily diary . 1 . Use therapeutic ( counter prescription ) body wash contains active ingredient eczema . 2 . Adults Females pregnant ( selfreported ) breastfeeding . 3 . Participation clinical study within 30 day Visit 1 . 4 . Atopic Dermatitis require systemic , superpotent ( Class I ) potent ( Class II III ) topical corticosteroid . 5 . Requires great 2.0 mg/day inhale intranasal corticosteroid . 6 . Subjects exhibit clinically active bacterial , fungal , viral skin infection susceptible cutaneous infection . 7 . Subjects currently phototherapy .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Eczema</keyword>
	<keyword>Skin Irritation</keyword>
</DOC>